|Day Low/High||18.88 / 19.57|
|52 Wk Low/High||7.56 / 23.57|
The most recent short interest data has been released for the 11/30/2016 settlement date, which shows a 254,831 share decrease in total short interest for Flexion Therapeutics, Inc. , to 1,028,455, a decrease of 19.86% since 11/15/2016.
Investors considering a purchase of Flexion Therapeutics, Inc. shares, but tentative about paying the going market price of $17.89/share, might benefit from considering selling puts among the alternative strategies at their disposal.
Podium Presentation at the AAHKS Annual Meeting Shows Zilretta Delivers Extended Relief Compared to Immediate-Release Steroid and Placebo
In trading on Thursday, shares of Flexion Therapeutics, Inc. touched a new 52-week high of $22.00/share.
- Magee is a seasoned pharmaceutical executive with significant experience building effective sales teams and launching products -
An update on the market and my stock of the week, TPI Composites.
Flexion (FLXN) stock closed sharply lower on Wednesday after announcing plans to raise $77 million from a stock offering.
There is some good speculative trading and metals are the place to be.
Investors eyeing a purchase of Flexion Therapeutics, Inc. stock, but tentative about paying the going market price of $15.38/share, might benefit from considering selling puts among the alternative strategies at their disposal.